Go Pro

Cigna Group (CI) Competitors

Cigna Group logo
$284.62 -4.28 (-1.48%)
As of 10:20 AM Eastern
This is a fair market value price provided by Massive. Learn more.

CI vs. CNC, CVS, ELV, HCA, and HUM

Should you buy Cigna Group stock or one of its competitors? Cigna Group's main competitors and comparable companies include Centene (CNC), CVS Health (CVS), Elevance Health (ELV), HCA Healthcare (HCA), and Humana (HUM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Cigna Group compare to Centene?

Centene (NYSE:CNC) and Cigna Group (NYSE:CI) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation and dividends.

93.6% of Centene shares are held by institutional investors. Comparatively, 87.0% of Cigna Group shares are held by institutional investors. 0.4% of Centene shares are held by insiders. Comparatively, 0.6% of Cigna Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cigna Group has a net margin of 2.27% compared to Centene's net margin of -2.51%. Cigna Group's return on equity of 19.75% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Centene-2.51% 12.12% 3.20%
Cigna Group 2.27%19.75%5.34%

Centene currently has a consensus price target of $70.05, indicating a potential upside of 3.96%. Cigna Group has a consensus price target of $337.10, indicating a potential upside of 17.46%. Given Cigna Group's stronger consensus rating and higher probable upside, analysts plainly believe Cigna Group is more favorable than Centene.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene
2 Sell rating(s)
9 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.43
Cigna Group
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

In the previous week, Centene had 6 more articles in the media than Cigna Group. MarketBeat recorded 20 mentions for Centene and 14 mentions for Cigna Group. Centene's average media sentiment score of 0.93 beat Cigna Group's score of 0.86 indicating that Centene is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Centene
8 Very Positive mention(s)
4 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cigna Group
6 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Centene has a beta of 1.1, indicating that its share price is 10% more volatile than the broader market. Comparatively, Cigna Group has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market.

Cigna Group has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Centene$194.78B0.17-$6.67B-$10.44N/A
Cigna Group$274.90B0.28$5.96B$24.1711.87

Summary

Cigna Group beats Centene on 12 of the 17 factors compared between the two stocks.

How does Cigna Group compare to CVS Health?

CVS Health (NYSE:CVS) and Cigna Group (NYSE:CI) are both large-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

80.7% of CVS Health shares are owned by institutional investors. Comparatively, 87.0% of Cigna Group shares are owned by institutional investors. 0.9% of CVS Health shares are owned by company insiders. Comparatively, 0.6% of Cigna Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.8%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. CVS Health pays out 70.4% of its earnings in the form of a dividend. Cigna Group pays out 25.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. CVS Health has raised its dividend for 4 consecutive years and Cigna Group has raised its dividend for 5 consecutive years.

CVS Health has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market. Comparatively, Cigna Group has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market.

Cigna Group has a net margin of 2.27% compared to CVS Health's net margin of 1.18%. Cigna Group's return on equity of 19.75% beat CVS Health's return on equity.

Company Net Margins Return on Equity Return on Assets
CVS Health1.18% 13.12% 3.95%
Cigna Group 2.27%19.75%5.34%

In the previous week, CVS Health had 20 more articles in the media than Cigna Group. MarketBeat recorded 34 mentions for CVS Health and 14 mentions for Cigna Group. Cigna Group's average media sentiment score of 0.86 beat CVS Health's score of 0.76 indicating that Cigna Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVS Health
17 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Positive
Cigna Group
6 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Cigna Group has lower revenue, but higher earnings than CVS Health. Cigna Group is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVS Health$402.07B0.30$1.77B$3.7824.86
Cigna Group$274.90B0.28$5.96B$24.1711.87

CVS Health currently has a consensus target price of $107.24, indicating a potential upside of 14.10%. Cigna Group has a consensus target price of $337.10, indicating a potential upside of 17.46%. Given Cigna Group's higher probable upside, analysts plainly believe Cigna Group is more favorable than CVS Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVS Health
0 Sell rating(s)
1 Hold rating(s)
22 Buy rating(s)
0 Strong Buy rating(s)
2.96
Cigna Group
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

Summary

Cigna Group beats CVS Health on 10 of the 19 factors compared between the two stocks.

How does Cigna Group compare to Elevance Health?

Elevance Health (NYSE:ELV) and Cigna Group (NYSE:CI) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends, risk and media sentiment.

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.6%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. Elevance Health pays out 30.6% of its earnings in the form of a dividend. Cigna Group pays out 25.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 14 consecutive years and Cigna Group has increased its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 87.0% of Cigna Group shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 0.6% of Cigna Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Elevance Health has a net margin of 2.47% compared to Cigna Group's net margin of 2.27%. Cigna Group's return on equity of 19.75% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.47% 14.64% 5.22%
Cigna Group 2.27%19.75%5.34%

In the previous week, Elevance Health had 2 more articles in the media than Cigna Group. MarketBeat recorded 16 mentions for Elevance Health and 14 mentions for Cigna Group. Elevance Health's average media sentiment score of 0.99 beat Cigna Group's score of 0.86 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
10 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cigna Group
6 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Cigna Group has higher revenue and earnings than Elevance Health. Cigna Group is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$199.13B0.45$5.66B$22.5018.57
Cigna Group$274.90B0.28$5.96B$24.1711.87

Elevance Health presently has a consensus price target of $440.90, suggesting a potential upside of 5.54%. Cigna Group has a consensus price target of $337.10, suggesting a potential upside of 17.46%. Given Cigna Group's higher probable upside, analysts plainly believe Cigna Group is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65
Cigna Group
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

Elevance Health has a beta of 0.69, suggesting that its share price is 31% less volatile than the broader market. Comparatively, Cigna Group has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market.

Summary

Cigna Group beats Elevance Health on 9 of the 17 factors compared between the two stocks.

How does Cigna Group compare to HCA Healthcare?

HCA Healthcare (NYSE:HCA) and Cigna Group (NYSE:CI) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.

HCA Healthcare has higher earnings, but lower revenue than Cigna Group. Cigna Group is trading at a lower price-to-earnings ratio than HCA Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HCA Healthcare$78.01B1.18$6.78B$29.8714.20
Cigna Group$274.90B0.28$5.96B$24.1711.87

HCA Healthcare has a beta of 1.1, suggesting that its share price is 10% more volatile than the broader market. Comparatively, Cigna Group has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market.

HCA Healthcare pays an annual dividend of $3.12 per share and has a dividend yield of 0.7%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. HCA Healthcare pays out 10.4% of its earnings in the form of a dividend. Cigna Group pays out 25.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. HCA Healthcare has increased its dividend for 6 consecutive years and Cigna Group has increased its dividend for 5 consecutive years.

HCA Healthcare presently has a consensus price target of $462.64, suggesting a potential upside of 9.10%. Cigna Group has a consensus price target of $337.10, suggesting a potential upside of 17.46%. Given Cigna Group's stronger consensus rating and higher possible upside, analysts plainly believe Cigna Group is more favorable than HCA Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HCA Healthcare
1 Sell rating(s)
8 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.57
Cigna Group
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

62.7% of HCA Healthcare shares are owned by institutional investors. Comparatively, 87.0% of Cigna Group shares are owned by institutional investors. 1.5% of HCA Healthcare shares are owned by company insiders. Comparatively, 0.6% of Cigna Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

HCA Healthcare has a net margin of 8.77% compared to Cigna Group's net margin of 2.27%. Cigna Group's return on equity of 19.75% beat HCA Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
HCA Healthcare8.77% -244.79% 11.10%
Cigna Group 2.27%19.75%5.34%

In the previous week, HCA Healthcare had 5 more articles in the media than Cigna Group. MarketBeat recorded 19 mentions for HCA Healthcare and 14 mentions for Cigna Group. Cigna Group's average media sentiment score of 0.86 beat HCA Healthcare's score of 0.57 indicating that Cigna Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HCA Healthcare
7 Very Positive mention(s)
4 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cigna Group
6 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

HCA Healthcare beats Cigna Group on 11 of the 19 factors compared between the two stocks.

How does Cigna Group compare to Humana?

Humana (NYSE:HUM) and Cigna Group (NYSE:CI) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.9%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. Humana pays out 33.5% of its earnings in the form of a dividend. Cigna Group pays out 25.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has increased its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Humana has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market. Comparatively, Cigna Group has a beta of 0.31, indicating that its stock price is 69% less volatile than the broader market.

Humana presently has a consensus target price of $403.91, suggesting a potential upside of 3.67%. Cigna Group has a consensus target price of $337.10, suggesting a potential upside of 17.46%. Given Cigna Group's stronger consensus rating and higher probable upside, analysts clearly believe Cigna Group is more favorable than Humana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Humana
1 Sell rating(s)
15 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.43
Cigna Group
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

92.4% of Humana shares are held by institutional investors. Comparatively, 87.0% of Cigna Group shares are held by institutional investors. 0.2% of Humana shares are held by insiders. Comparatively, 0.6% of Cigna Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cigna Group has higher revenue and earnings than Humana. Cigna Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Humana$129.66B0.36$1.19B$10.5736.86
Cigna Group$274.90B0.28$5.96B$24.1711.87

In the previous week, Cigna Group had 1 more articles in the media than Humana. MarketBeat recorded 14 mentions for Cigna Group and 13 mentions for Humana. Humana's average media sentiment score of 1.10 beat Cigna Group's score of 0.86 indicating that Humana is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Humana
7 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cigna Group
6 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Cigna Group has a net margin of 2.27% compared to Humana's net margin of 0.88%. Cigna Group's return on equity of 19.75% beat Humana's return on equity.

Company Net Margins Return on Equity Return on Assets
Humana0.88% 11.20% 3.94%
Cigna Group 2.27%19.75%5.34%

Summary

Cigna Group beats Humana on 14 of the 19 factors compared between the two stocks.

Get Cigna Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CI vs. The Competition

MetricCigna GroupHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$75.76B$10.00B$7.21B$23.21B
Dividend Yield2.15%2.61%2.57%3.58%
P/E Ratio11.8633.86272.8628.41
Price / Sales0.285.00706.1520.40
Price / Cash7.08126.2577.7134.34
Price / Book1.815.3710.444.69
Net Income$5.96B$313.45M$3.49B$1.07B
7 Day Performance3.12%0.24%-0.76%-1.48%
1 Month Performance1.68%-1.07%-0.38%-4.27%
1 Year Performance-2.35%16.93%18.93%8.97%

Cigna Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CI
Cigna Group
4.6432 of 5 stars
$284.62
-1.5%
$337.10
+18.4%
-2.8%$75.19B$274.90B11.7767,700
CNC
Centene
3.3504 of 5 stars
$66.92
-0.2%
$70.05
+4.7%
+106.9%$33.06B$194.78BN/A61,100
CVS
CVS Health
4.594 of 5 stars
$96.80
+0.1%
$106.83
+10.4%
+28.6%$123.80B$402.07B25.61300,000
ELV
Elevance Health
4.2216 of 5 stars
$407.05
-0.1%
$440.90
+8.3%
+35.9%$88.28B$199.13B18.0997,100
HCA
HCA Healthcare
3.5976 of 5 stars
$404.95
0.0%
$462.64
+14.2%
+4.9%$87.67B$75.60B13.56320,000

Related Companies and Tools


This page (NYSE:CI) was last updated on 9/16/2026 by MarketBeat.com Staff.
From Our Partners